CO5190716A1 - 4,4-diaril-ciclohexanos 1,4-sustituidos - Google Patents

4,4-diaril-ciclohexanos 1,4-sustituidos

Info

Publication number
CO5190716A1
CO5190716A1 CO00059896A CO00059896A CO5190716A1 CO 5190716 A1 CO5190716 A1 CO 5190716A1 CO 00059896 A CO00059896 A CO 00059896A CO 00059896 A CO00059896 A CO 00059896A CO 5190716 A1 CO5190716 A1 CO 5190716A1
Authority
CO
Colombia
Prior art keywords
cr4r5
substituted
hydroxyl
alkyl
tetrahydrothiopyranyl
Prior art date
Application number
CO00059896A
Other languages
English (en)
Inventor
Iv Siegfried B Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5190716A1 publication Critical patent/CO5190716A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

Un compuesto de fórmula (I)<EMI FILE="00059896_1" ID="1" IMF=JPEG >en la que:R1 es -(CR4R5)nC(O)O(CR4R5)mR6,-(CR4R5)nC(O)NR4(CR4R5)mR6,-(CR4R5)nO(CR4R5)mR6 ó -(CR4R5)rR6, donde los restos alquilo están sin sustituir o sustituidos con uno o más halógenos;m es 0 a 2;n es 1 a 4; r es 0 a 6;R4 y R5 se seleccionan independientemente entre hidrógeno o alquilo C1-2;R6 es hidrógeno, metilo, hidroxilo, arilo, arilo sustituido con halo, ariloxi-alquilo C1-3, ariloxi-alquilo C1-3 sustituido con halo, indanilo, indenilo, policicloalquilo C7-11, tetrahidrofuranilo, furanilo, tetrahidropiranilo, piranilo, tetrahidrotienilo, tienilo, tetrahidrotiopiranilo, tiopiranilo, cicloalquilo C3-6 o un cicloalquilo C4-6 que contiene uno o dos enlaces insaturados, donde el resto cicloalquilo o heterocíclico está sin sustituir o sustituido con 1 a 3 grupos metilo, un grupo etilo o un grupo hidroxilo;con la condición de que a) cuando R6 es hidroxilo, entonces m sea 2; o b) cuando R6 es hidroxilo, entonces r sea 2 a 6; o c) cuando R6 es 2-tetrahidropiranilo, 2-tetrahidrotiopiranilo, 2-tetrahidrofuranilo o 2-tetrahidrotienilo entonces m sea 1 ó 2; od) cuando R6 es 2-tetrahidropiranilo, 2-tetrahidrotiopiranilo, 2-tetrahidrofuranilo o 2-tetrahidrotienilo, entonces r sea 1 a 6;e) cuando n es 1 y m es 0, entonces R6 sea distinto de H en -(CR4R5)nO(CR4R5)mR6;X es YR2, flúor, NR4R5 o formil-amina;Y es O o S(O)m´;m´ es 0, 1 ó 2;X2 es O o NR8;X4 es H, R9, OR8, CN, C(O)R8, C(O)OR8, C(O)NR8R8 ó NR8R8;R2 se selecciona independientemente entre -CH3 o -CH2CH3 opcionalmente sustituido con 1 o más halógenos; s es 0 a 4;Ar es fenilo sin sustituir o sustituido con R7; ...
CO00059896A 1999-08-10 2000-08-10 4,4-diaril-ciclohexanos 1,4-sustituidos CO5190716A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14803499P 1999-08-10 1999-08-10

Publications (1)

Publication Number Publication Date
CO5190716A1 true CO5190716A1 (es) 2002-08-29

Family

ID=22523946

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00059896A CO5190716A1 (es) 1999-08-10 2000-08-10 4,4-diaril-ciclohexanos 1,4-sustituidos

Country Status (19)

Country Link
US (1) US6518306B1 (es)
EP (1) EP1202955A4 (es)
JP (1) JP2003522129A (es)
KR (1) KR20020022102A (es)
CN (1) CN1368952A (es)
AU (1) AU6763900A (es)
BR (1) BR0013230A (es)
CA (1) CA2378990A1 (es)
CO (1) CO5190716A1 (es)
CZ (1) CZ2002460A3 (es)
HU (1) HUP0202936A3 (es)
IL (1) IL148032A0 (es)
MX (1) MXPA02001471A (es)
NO (1) NO20020597L (es)
NZ (1) NZ516620A (es)
PL (1) PL353360A1 (es)
TR (1) TR200200347T2 (es)
WO (1) WO2001010385A2 (es)
ZA (1) ZA200201036B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
US20040001895A1 (en) * 2002-06-17 2004-01-01 Pfizer Inc. Combination treatment for depression and anxiety
UA83266C2 (en) * 2003-12-08 2008-06-25 Уайет Oxazole derivatives of tetracyclines
JP4869221B2 (ja) * 2004-04-08 2012-02-08 ワイス・エルエルシー プロゲステロン受容体調節剤としてのチオアミド誘導体
BRPI0509159B1 (pt) * 2004-04-08 2014-08-26 Wyeth Llc Processo para preparar um composto de fenoxicicloalquila
US7825265B2 (en) 2004-05-04 2010-11-02 Acadia Pharmaceuticals Inc. Compounds with activity at estrogen receptors
WO2005108337A2 (en) * 2004-05-04 2005-11-17 Acadia Pharmaceuticals Inc. Compounds with activity at estrogen receptor
KR100694873B1 (ko) * 2005-05-26 2007-03-13 주식회사 대인정밀 정수기
TW200716536A (en) * 2005-06-09 2007-05-01 Chugai Pharmaceutical Co Ltd Vitamin D compounds
CA2702225A1 (en) * 2007-10-10 2009-04-16 Merck Sharp & Dohme Corp. Diphenyl substituted cycloalkanes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019750A1 (en) * 1992-04-02 1993-10-14 Smithkline Beecham Corporation Compounds useful for treating allergic or inflammatory diseases
WO1993019748A1 (en) * 1992-04-02 1993-10-14 Smithkline Beecham Corporation Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
JPH07278038A (ja) * 1994-04-01 1995-10-24 Sumitomo Chem Co Ltd 多官能ビニルエーテル化合物
AU708349B2 (en) * 1994-12-23 1999-08-05 Smithkline Beecham Corporation 4,4-(disubstituted)cyclohexan-1-one monomers and related compounds
NZ301096A (en) * 1994-12-23 1999-01-28 Smithkline Beecham Corp 4,4-(disubstituted)cyclohexan-1-ol monomer and related derivatives; medicaments containing them
AR004471A1 (es) * 1995-05-31 1998-12-16 Smithkline Beecham Corp Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen
UY25338A1 (es) * 1998-01-07 2001-08-27 Smithkline Beecham Corp Método para tratar copd

Also Published As

Publication number Publication date
KR20020022102A (ko) 2002-03-23
HUP0202936A3 (en) 2003-11-28
HUP0202936A2 (hu) 2002-12-28
IL148032A0 (en) 2002-09-12
AU6763900A (en) 2001-03-05
PL353360A1 (en) 2003-11-17
CA2378990A1 (en) 2001-02-15
EP1202955A4 (en) 2004-02-11
TR200200347T2 (tr) 2002-06-21
WO2001010385A3 (en) 2001-08-16
US6518306B1 (en) 2003-02-11
WO2001010385A2 (en) 2001-02-15
EP1202955A2 (en) 2002-05-08
ZA200201036B (en) 2003-04-30
MXPA02001471A (es) 2002-07-02
NO20020597L (no) 2002-04-03
CN1368952A (zh) 2002-09-11
NZ516620A (en) 2004-03-26
NO20020597D0 (no) 2002-02-06
BR0013230A (pt) 2002-04-23
JP2003522129A (ja) 2003-07-22
CZ2002460A3 (cs) 2002-06-12

Similar Documents

Publication Publication Date Title
CO5190716A1 (es) 4,4-diaril-ciclohexanos 1,4-sustituidos
TW200506520A (en) Novel photosensitive resin compositions
CO4480100A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol-, y procedimiento de preparacion para dichos compuestos
UA7589A1 (uk) Спосіб одержання (1-арілціклобутіл)-алкіламінів або їх фармакологічно припущених солей
AR050308A2 (es) Derivados del acido 4- fenil-4-ciano-ciclohexanoico
Hondrogiannis et al. The diels-alder reaction of cyclopentadiene and methyl acrylate on γ,-alumina
KR880000477A (ko) 유리한 개질성분을 포함하는 알파-올레핀 중합촉매 시스템
AR014411A1 (es) El uso de derivados de fenil-ciclohexano sustituidos para la manufactura de un medicamento para el tratamiento profilactico de un mamifero en situacionde riesgo de desarrollar copd.
PE20031054A1 (es) Proceso para la preparacion de 5,6-dietil-2,3-dihidro-1h-inden-2-amina
AR004471A1 (es) Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen
KR840005070A (ko) 아미노알카디엔 유도체의 제조방법
CO4700281A1 (es) Monomeros de 4,4-(disustituido) ciclohexan-1-oles y compuestos relacionados
BR0206252A (pt) Catalisador para polimerização e co-polimerização de etileno
KR960022693A (ko) 부분적으로 보호된 페놀성 수지의 제조방법
CO5241281A1 (es) Procedimientos e intermdedios para preparar acidos ( 4-cianosustituido)-ciclohexanoicos
DE69814572D1 (de) Herstellung von Boratverbindungen
GB917436A (en) Process for the production of substituted vinylamines
CO5190744A1 (es) Procedimiento para preparar acidos a traves de alfa- cloroepoxi-esteres
ECSP066469A (es) Procedimiento para preparar compuestos de 1-[ciano(fenil)metil]-ciclohexanol
JP2003233188A5 (es)
AR039384A1 (es) Proceso para la preparacion de sales de dicetonas biciclicas
MY140860A (en) Novel substituted 1,2,4- trioxanes, useful as antimalarial agents, and a process for the preparation thereof
Hata et al. THE EFFECT OF EXTERNAL MAGNETIC FIELD ON THE PHOTOINDUCED SUBSTITUTION REACTION OF 4-METHYLQUINOLINE-2-CARBONITRILE IN ETHANOL
CO5251403A1 (es) Proceso para preparar compuestos triciclicos que tienen actividad antihistaminica, en especial loratadina y descarboetoxiloratadina
JPS5469162A (en) Stabilized urethane polymer

Legal Events

Date Code Title Description
FC Application refused